Stay updated on Organon & Co. Press Releases
Sign up to get notified when there's something new on the Organon & Co. Press Releases page.
Latest updates to the Organon & Co. Press Releases page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedOrganon has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference and received FDA approval for VTAMA® cream for atopic dermatitis, while previous updates regarding a licensing agreement and positive study results for OG-8276A have been removed.SummaryDifference89%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe website has added new content, while the 'Cookie Preferences' section has been removed.SummaryDifference0.5%
- Check46 days agoChange DetectedThe website has added new content, while the 'Cookie Preferences' section has been removed.SummaryDifference0.5%
- Check53 days agoChange DetectedThe website has added a 'Cookie Preferences' section while removing a significant number of menu items, including product listings, corporate governance details, and various regional site links.SummaryDifference52%
- Check67 days agoChange DetectedThe website has added extensive new sections including product information, leadership details, and regional directories, while removing a recent announcement about a new executive appointment and updating the FDA review status for VTAMA®.SummaryDifference100%
- Check75 days agoChange DetectedOrganon has reported its third quarter results for 2024 and announced the acceptance of a BLA for its biosimilar candidate HLX14, while also completing the acquisition of Dermavant, which includes the innovative therapy VTAMA®.SummaryDifference74%
Stay in the know with updates to Organon & Co. Press Releases
Enter your email address, and we'll notify you when there's something new on the Organon & Co. Press Releases page.